Clin Mol Hepatol.
2024 Oct;30(4):1016-1018. 10.3350/cmh.2024.0365.
Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- 2Department of Health Service Administration, College of Public Health, China Medical University, Taichung, Taiwan
- 3Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- 4School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- 5Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- KMID: 2560113
- DOI: http://doi.org/10.3350/cmh.2024.0365
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma
- Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
- Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
- The application of machine learning for predicting recurrence in patients with early-stage endometrial cancer: a pilot study
